KPTI
Karyopharm Therapeutics Inc
Price:  
0.66 
USD
Volume:  
571,522.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KPTI WACC - Weighted Average Cost of Capital

The WACC of Karyopharm Therapeutics Inc (KPTI) is 6.5%.

The Cost of Equity of Karyopharm Therapeutics Inc (KPTI) is 10.30%.
The Cost of Debt of Karyopharm Therapeutics Inc (KPTI) is 5.50%.

Range Selected
Cost of equity 8.20% - 12.40% 10.30%
Tax rate 0.20% - 0.20% 0.20%
Cost of debt 4.00% - 7.00% 5.50%
WACC 4.9% - 8.1% 6.5%
WACC

KPTI WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.95 1.34
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.20% 12.40%
Tax rate 0.20% 0.20%
Debt/Equity ratio 3.64 3.64
Cost of debt 4.00% 7.00%
After-tax WACC 4.9% 8.1%
Selected WACC 6.5%